Drawing for NUEVOLUTION

USPTO serial 79234737

NUEVOLUTION

Reviewed by CopyMark Law Group

Reg. 5796494Status 709
Filing date
Status date
Registration date
Jul 9, 2019
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUEVOLUTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.One Amgen Center DriveTrademarks Operations MS-28-5AThousand Oaks, CA 91320-1799

Goods and services

ClassDescriptionStatusFirst use
001DNA preparations for scientific purposesSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment, prevention and alleviation of human diseases within oncology and for the treatment, prevention and alleviation of inflammatory diseases; pharmaceutical preparations for the treatment, prevention and alleviation of diseases within oncology and for the treatment, prevention and alleviation of inflammatory diseases; veterinary preparations for the treatment of diseases within oncology and for the treatment of inflammatory diseases; pharmaceutical preparations in the nature of analgesics, antibiotics, anti-cancer preparations, anti-infectives, anti-parasitics, antivirals, insulin, hormones and vaccines; biological and non-biological preparations for medical and veterinary purposes, namely, for the treatment, prevention and alleviation of diseases within oncology and for the treatment, prevention and alleviation of inflammatory diseases; enzymes and enzyme preparations for medical and veterinary purposes; DNA preparations for medical, medical diagnostic, and veterinary purposesSECTION 71 - CANCELLED—
042Scientific research and industrial research in the field of development of drug treatments for diseases within oncology and inflammatory diseases; scientific research in the field of genetics and enzymes; product research and development related to medical and veterinary drugs and preparations, product research and development in the biotechnology field, product research and development in the healthcare field; Scientific research and industrial research in the field of development, processing and utilisation of enzymes; molecular research; development for others of scientific research and testing processes and methods for medical and veterinary purposes; development of pharmaceutical preparations for medical and veterinary purposes; scientific research related to identification of drug candidates; scientific research and development in the field of in vitro and in vivo methods for the manufacture of biological and non-biological molecules, and of peptides and macrocyclic molecules and derivatives thereof and small molecules and derivatives thereofSECTION 71 - CANCELLED—
044Medical screening related to identification of drug candidatesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 23, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 23, 2026C71TCANCELLED SECTION 71—
Jul 9, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 24, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 20, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 9, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 9, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 9, 2022EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
May 9, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 9, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 12, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 12, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 12, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 12, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 12, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 12, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 8, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 23, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 23, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 9, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 9, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 3, 2019GPNXNOTIFICATION PROCESSED BY IB—
Apr 23, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 3, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 19, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 18, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 25, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 25, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 25, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 25, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 12, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 12, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 12, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 25, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 16, 2019ALIEASSIGNED TO LIE—
Jan 11, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 11, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 27, 2018RFNTREFUSAL PROCESSED BY IB—
Jul 12, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 12, 2018RFRRREFUSAL PROCESSED BY MPU—
Jun 29, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 28, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 22, 2018DOCKASSIGNED TO EXAMINER—
Jun 22, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 21, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance